Mufg Securities Emea PLC Jazz Pharmaceuticals PLC Transaction History

Mufg Securities Emea PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$95.68 - $121.88 $5.28 Million - $6.73 Million	-55,200 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$87.74 - $152.74 $1.95 Million - $3.39 Million	22,200 Added 67.27%	55,200 $5.51 Million
Q4 2019 Feb 11, 2020	BUY	$117.65 - $153.73 $988,260 - $1.29 Million	8,400 Added 34.15%	33,000 $4.93 Million
Q3 2019 Nov 12, 2019	BUY	$125.18 - $143.24 $3.08 Million - $3.52 Million	24,600 New	24,600 $3.15 Million
Q2 2019 Aug 13, 2019	SELL	$125.55 - $144.48 $3.03 Million - $3.49 Million	-24,151 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$121.81 - $142.95 $11.6 Million - $13.7 Million	-95,500 Reduced 79.82%	24,151 $3.45 Million
Q4 2018 Feb 14, 2019	BUY	$115.94 - $166.74 $13.9 Million - $20 Million	119,651 New	119,651 $14.8 Million

516

57.8M

188K

110K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.54B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Mufg Securities Emea PLC, based on Form 13F filings with the SEC.

Stay updated on Mufg Securities Emea PLC with notifications on news.